Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MATTHEW S DAVIDS

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1659541522
CMS profile
257015
Location
BOSTON, MA

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2025 · Entire year

$73,100.12

54 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

Other CMS categories — not shown on this page

Research Payments

CMS also publishes Research Payments as a separate dataset. This site does not currently mirror it, and no research figure is shown on this page. This provider appears in that dataset.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

These records are published by CMS and can be viewed on this provider’s official CMS record. View this provider on CMS Open Payments ↗

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2025 · entire year · sorted by reported total

By paying entity

PY2025 · entire year · sorted by reported total

Paying entityAmountRecords
Lilly USA, LLC $14,945.43 5
ABBVIE INC. $14,714.85 16
AstraZeneca Pharmaceuticals LP $11,939.69 10
BeOne Medicines USA, Inc. $8,400.06 7
AstraZeneca UK Limited $8,120.28 6
Merck Sharp & Dohme LLC $7,040.00 2
Eli Lilly and Company $3,884.81 4
Janssen Biotech, Inc. $1,800.00 1
BeiGene USA, Inc. $1,300.00 2
E.R. Squibb & Sons, L.L.C. $955.00 1

Payment records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2025 · Physicians and non-physician practitioners · CMS publication 2026-06-30

54 matching records · $73,100.12 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 54 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–50 of 54.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
ABBVIE INC. $67.9812/25/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261201731960 CMS
ABBVIE INC. $1,600.0012/19/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261201731958 CMS
BeOne Medicines USA, Inc. $1,600.0012/16/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261202884464 CMS
BeOne Medicines USA, Inc. $150.0012/16/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261202884466 CMS
AstraZeneca UK Limited $1,230.0012/15/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261211398618 CMS
ABBVIE INC. $15.5112/12/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201731954 CMS
ABBVIE INC. $60.9812/12/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261201731956 CMS
AstraZeneca Pharmaceuticals LP $134.9912/07/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261215348290 CMS
AstraZeneca UK Limited $45.2812/06/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261211398694 CMS
ABBVIE INC. $24.9512/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201731948 CMS
ABBVIE INC. $24.2612/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201731950 CMS
ABBVIE INC. $77.9812/05/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201731952 CMS
ABBVIE INC. $122.9512/04/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201731946 CMS
Lilly USA, LLC $1,350.0011/07/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186802147 CMS
ABBVIE INC. $400.0011/03/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261201731944 CMS
Merck Sharp & Dohme LLC $4,480.0011/03/2025 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: NEW
06/30/20261237999496 CMS
AstraZeneca UK Limited $1,370.0010/24/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261211398696 CMS
AstraZeneca UK Limited $1,370.0010/24/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261211400154 CMS
ABBVIE INC. $400.0009/30/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261201731942 CMS
BeOne Medicines USA, Inc. $1,500.0009/29/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261202884460 CMS
E.R. Squibb & Sons, L.L.C. $955.0009/18/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261184759468 CMS
Lilly USA, LLC $699.6808/07/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186777701 CMS
Lilly USA, LLC $95.7508/07/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261186816417 CMS
BeOne Medicines USA, Inc. $100.0007/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261202884454 CMS
BeOne Medicines USA, Inc. $2,000.0007/28/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261202884456 CMS
Eli Lilly and Company $14.8107/28/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261186753713 CMS
AstraZeneca Pharmaceuticals LP $685.0007/17/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261215334085 CMS
AstraZeneca Pharmaceuticals LP $1,370.0007/07/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261215329580 CMS
ABBVIE INC. $400.0006/30/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261201731940 CMS
Eli Lilly and Company $1,800.0006/20/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186753711 CMS
Lilly USA, LLC $9,200.0006/20/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186816415 CMS
AstraZeneca UK Limited $2,050.0006/19/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261211398506 CMS
BeOne Medicines USA, Inc. $50.0606/14/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261202884462 CMS
Eli Lilly and Company $720.0006/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261186767370 CMS
Merck Sharp & Dohme LLC $2,560.0005/28/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261238036352 CMS
ABBVIE INC. $4,000.0005/13/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261201731938 CMS
AstraZeneca Pharmaceuticals LP $4,920.0005/05/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261215333104 CMS
BeOne Medicines USA, Inc. $3,000.0004/29/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261202884458 CMS
ABBVIE INC. $120.2403/13/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261201731936 CMS
ABBVIE INC. $400.0003/03/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261201731934 CMS
BeiGene USA, Inc. $100.0002/23/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261202877904 CMS
BeiGene USA, Inc. $1,200.0002/23/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261202877906 CMS
Lilly USA, LLC $3,600.0002/18/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186753715 CMS
Eli Lilly and Company $1,350.0002/14/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261186839263 CMS
AstraZeneca Pharmaceuticals LP $383.5101/29/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261214779560 CMS
AstraZeneca Pharmaceuticals LP $20.4701/29/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261214797761 CMS
AstraZeneca Pharmaceuticals LP $107.0001/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261214774174 CMS
AstraZeneca Pharmaceuticals LP $143.1801/27/2025 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/20261214785513 CMS
AstraZeneca Pharmaceuticals LP $75.5401/27/2025 Travel and Lodging No dispute reported Delay: No
Change: NEW
06/30/20261214791857 CMS
AstraZeneca Pharmaceuticals LP $4,100.0001/21/2025 Consulting Fee No dispute reported Delay: No
Change: NEW
06/30/20261214802979 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $87,831.66 82
PY2020 $97,922.33 40
PY2021 $82,253.37 52
PY2022 $122,774.83 52
PY2023 $127,037.76 76
PY2024 $101,636.19 68
PY2025 $73,100.12 54

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Cite this record.

Plain
MATTHEW S DAVIDS, NPI 1659541522. IndustryPayments, data edition 2026-07-26T04:22:22Z. https://industrypayments.org/provider/npi-1659541522.
APA 7
IndustryPayments. (2026). MATTHEW S DAVIDS, NPI 1659541522 (Data edition 2026-07-26T04:22:22Z) [Data set]. https://industrypayments.org/provider/npi-1659541522
Bluebook
MATTHEW S DAVIDS, NPI 1659541522, IndustryPayments (data edition 2026-07-26T04:22:22Z), https://industrypayments.org/provider/npi-1659541522.

Source: Centers for Medicare & Medicaid Services, Open Payments.